[go: up one dir, main page]

NO921831L - Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat - Google Patents

Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat

Info

Publication number
NO921831L
NO921831L NO92921831A NO921831A NO921831L NO 921831 L NO921831 L NO 921831L NO 92921831 A NO92921831 A NO 92921831A NO 921831 A NO921831 A NO 921831A NO 921831 L NO921831 L NO 921831L
Authority
NO
Norway
Prior art keywords
atoms
consumptions
derivative
procedures
preparing
Prior art date
Application number
NO92921831A
Other languages
English (en)
Norwegian (no)
Other versions
NO921831D0 (no
Inventor
Henning Boettcher
Christoph Seyfried
Gerd Bartoszyk
Klaus-Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO921831D0 publication Critical patent/NO921831D0/no
Publication of NO921831L publication Critical patent/NO921831L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO92921831A 1991-05-10 1992-05-08 Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat NO921831L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4115215A DE4115215A1 (de) 1991-05-10 1991-05-10 Indolderivate

Publications (2)

Publication Number Publication Date
NO921831D0 NO921831D0 (no) 1992-05-08
NO921831L true NO921831L (no) 1992-11-11

Family

ID=6431344

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921831A NO921831L (no) 1991-05-10 1992-05-08 Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat

Country Status (14)

Country Link
EP (1) EP0512350A3 (zh)
JP (1) JPH05155886A (zh)
KR (1) KR920021507A (zh)
AU (1) AU1604492A (zh)
CA (1) CA2068238A1 (zh)
CS (1) CS130592A3 (zh)
DE (1) DE4115215A1 (zh)
HU (1) HU208136B (zh)
IE (1) IE921488A1 (zh)
MX (1) MX9202152A (zh)
NO (1) NO921831L (zh)
PL (1) PL294457A2 (zh)
TW (1) TW221807B (zh)
ZA (1) ZA923351B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE125808T1 (de) * 1990-08-31 1995-08-15 Nippon Shinyaku Co Ltd Indolederivate und ihre verwendung als serotonin- antagoniste.
IT1255467B (it) * 1992-07-29 1995-11-02 Dompe Farmaceutici Spa Ammidi acriliche farmacologicamente attive
WO2002016357A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
WO2002016358A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
DE10045112A1 (de) * 2000-09-11 2002-03-21 Merck Patent Gmbh Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
DK1432707T3 (da) 2001-10-02 2012-06-11 Pharmacia & Upjohn Co Llc Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
WO2003070731A2 (en) 2002-02-19 2003-08-28 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
BR0307735A (pt) 2002-02-19 2005-01-25 Upjohn Co Carboxamidas heteroaromáticas com ligação-n em ponte biciclìcas fundidas para o tratamento de doença
US7176198B2 (en) 2002-08-01 2007-02-13 Pfizer Inc. 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
WO2009158375A1 (en) * 2008-06-25 2009-12-30 Abbott Laboratories Aza-cylic indole- 2 -carboxamides and methods of use thereof
HUE037938T2 (hu) 2008-11-19 2018-09-28 Forum Pharmaceuticals Inc Skizofrénia negatív tüneteinek kezelése (R)-7-klór-N-(kinuklidin-3-il)benzo[b]tiofén-2-karboxamiddal és ennek gyógyszerészetileg elfogadható sójával
MY165234A (en) 2010-05-17 2018-03-14 Forum Pharmaceuticals Inc A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
DE3881950T2 (de) * 1987-04-25 1993-09-30 Beecham Group Plc Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben

Also Published As

Publication number Publication date
JPH05155886A (ja) 1993-06-22
MX9202152A (es) 1992-11-01
DE4115215A1 (de) 1992-11-12
AU1604492A (en) 1992-11-12
IE921488A1 (en) 1992-11-18
NO921831D0 (no) 1992-05-08
EP0512350A2 (de) 1992-11-11
HU9201550D0 (en) 1992-07-28
EP0512350A3 (en) 1992-12-16
CS130592A3 (en) 1992-11-18
KR920021507A (ko) 1992-12-18
PL294457A2 (en) 1992-11-16
HU208136B (en) 1993-08-30
ZA923351B (en) 1993-01-27
CA2068238A1 (en) 1992-11-11
TW221807B (zh) 1994-03-21
HUT61541A (en) 1993-01-28

Similar Documents

Publication Publication Date Title
NO921831L (no) Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat
ATE264103T1 (de) Urokinase-inhibitoren
PT1378510E (pt) Derivados de triazaespiro [5.5] undecano e farmacos que os contem como componentes activos
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
NO20050648L (no) Heterocyklisk substituerte benzoylureaer, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
NO20062136L (no) Imidazopyrazintyrosin-kinaseinhibitorer
EA200400305A1 (ru) 2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность
JP2003502272A5 (zh)
ES2054009T3 (es) Agentes antihipertensores de glutaramida cicloalquil sustituida.
BRPI0418328A (pt) controle de parasitas em animais pelo uso de derivados de imidazo [1,2-b]piridazina
WO2003062200A3 (en) Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
NO904134L (no) Fremgangsmaate for fremstilling av pyrazolderivater.
HUT75113A (en) 4-substituted piperidine derivatives useful as neurokinin antagonists
PT1236726E (pt) Derivados de triazaespiro[5.5]undecano e farmacos que os contem como ingrediente activo
YU97292A (sh) N-fenilalanil i n-fenilglicil derivati dipeptida l-azetidin-2-karboksilne kiseline
NO307378B1 (no) Optisk rene salter av pyridinylmetylsulfinyl-1H- benzimidazolforbindelser, fremgangsmåte for deres fremstilling, farmasøytisk preparat inneholdende slike forbindelser og deres anvendelse samt mellomprodukter
HK1098742A1 (en) Substituted 1h-pyrrolo [3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
NO20014363L (no) 4-okso-4,7-dihydro-tieno[2,3-b]pyridin-5-karboksamider som antivirale midler
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
BR0313407A (pt) Novo uso de derivados de benzotiazol
PT98583A (pt) Processo para a preparacao de compostos pirrolicos substituidos e de composico-es farmaceuticas que os contem
MXPA01007940A (es) Derivados de azabicicloalcano y usos terapeuticos de los mismos.
NO170934C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme 1,4-dihydropyridinderivater
HK1058515A1 (en) Use of pamoic acid for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates.
BR0306148A (pt) Compostos, composições farmacêuticas, e, uso de um composto